Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.

Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Thomas Maniatis is clinical ethicist at the Douglas Institute.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

David Laplante has been studying the link between prenatal stress and early childhood development.

Jean Caron's research relates mainly to the epidemiology of mental illnesses and suicide.

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Jorge Armony, PhD conducts research on how the brain detects danger stimuli and how it interacts with consciousness and memory.

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...